Score Overview
Explore the 2021 public Archive ranking →
Where Lisata Therapeutics Inc. has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. LSTA does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-23 | $ 1.00 | — |
1 Year2025-10-23 | $ 2.35 | -57.62% |
5 Years2021-10-22 | $ 16.80 | -94.07% |
10 Years2016-10-21 | $ 63.75 | -98.44% |
20 Years2006-10-23 | $ 12.74K | -99.99% |
30 Years1996-10-17 | $ 28.11K | -100.00% |
All Time1999-03-01 | $ 173.37K | -100.00% |
| Period | Last Price2026-10-23 | 1 Year2025-10-23 | 5 Years2021-10-22 | 10 Years2016-10-21 | 20 Years2006-10-23 | 30 Years1996-10-17 | All Time1999-03-01 |
|---|---|---|---|---|---|---|---|
| Price | $ 1.00 | $ 2.35 | $ 16.80 | $ 63.75 | $ 12.74K | $ 28.11K | $ 173.37K |
| Return | — | -57.62% | -94.07% | -98.44% | -99.99% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 100K | -$ 14M | $ 10M |
| 2025 | $ 170K | -$ 16M | $ 15M |
| 2024 | $ 1M | -$ 19M | $ 31M |
| 2023 | $ 0.00 | -$ 20M | $ 50M |
| 2022 | $ 121M | -$ 54M | $ 69M |
| 2021 | $ 0.00 | -$ 27M | $ 94M |
| 2020 | $ 0.00 | -$ 8M | $ 34M |
| 2019 | $ 0.00 | -$ 20M | $ 25M |
| 2018 | $ 0.00 | -$ 16M | $ 43M |
| 2017 | $ 22M | $ 55M | |
| 2016 | $ 35M | -$ 32M | $ 14M |
| 2015 | $ 22M | -$ 80M | $ 20M |
| 2014 | $ 17M | -$ 54M | $ 26M |
| 2013 | $ 14M | -$ 38M | $ 46M |
| 2012 | $ 14M | -$ 54M | $ 13M |
| 2011 | $ 10M | -$ 47M | $ 3M |
| 2010 | $ 69M | -$ 23M | $ 15M |
| 2009 | $ 11M | -$ 26M | $ 7M |
| 2008 | -$ 9M | $ 430.79K | |
| 2007 | $ 231.66K | -$ 10M | $ 2M |
| 2006 | $ 45.72K | -$ 6M | $ 436.66K |
| 2005 | $ 35.26K | -$ 1M | $ 488.87K |
| 2004 | $ 48.56K | -$ 1M | $ 27.87K |
| 2003 | $ 64.63K | -$ 1M | $ 210.95K |
| 2002 | $ 81.35K | -$ 1M | $ 19.25K |
| 2001 | $ 107.45K | -$ 2M | $ 1M |
| 2000 | $ 531.76K | -$ 2M | $ 2M |
| IPO1999 | $ 12.85K | -$ 1M | $ 4M |
Lisata Therapeutics Inc. fundamental performance
Between 2015 and 2025, revenue declined from $ 22M to $ 170K and net income went from -$ 80M to -$ 16M. Revenue increased in 3 of those 10 years; net income in 6.
Across Lisata Therapeutics Inc.'s full reported history, from 1999 to 2025, revenue grew from $ 12.85K to $ 170K and net income went from -$ 1M to -$ 16M. Revenue increased in 48% of the years measured; net income in 48%.
Lisata Therapeutics Inc. currently holds a 20-year HDB Score of 2.6 out of 10. How the HDB Score is calculated.
Membership
Explore LSTA with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,112 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
